ArticleOpen forum infectious diseases2024
Microbiological Methods Used in the Enterics for Global Health
Open access · goldAbstract read
In one paragraph
Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 19 citations in OpenAlex.
- Fecal biomarkers to characterize intestinal inflammation among children with medically attended diarrhea across six low-resource settings: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study.PLoS neglected tropical diseases · 2026Article
- Genomic epidemiology and antimicrobial resistance profile ofMicrobial genomics · 2026Article
- Robust performance of culture, real-time PCR, and genomic approaches for shigella serotyping in a pediatric surveillance cohort.PLoS neglected tropical diseases · 2026Article
- The consequences ofEClinicalMedicine · 2026Article
- Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study.PLoS neglected tropical diseases · 2026Article
- Article
- The incidence and antimicrobial resistance of Shigella-attributable diarrhoea in young children in low-income and middle-income countries from the multicountry Enterics for Global Health (EFGH) Shigella Surveillance Study: a prospective, facility-based hybrid surveillance study.The Lancet. Global health · 2026Article
- OptimizingJournal of clinical microbiology · 2026Observational
- Robust Performance of Culture, qPCR, and Genomic Approaches for Shigella Serotyping in a Pediatric Surveillance Cohort.medRxiv : the preprint server for health sciences · 2026Article
- Novel Triazole-Carbohydrazide hydrazones with dual antioxidant and antibacterial potential.Scientific reports · 2025Article
- Article
- One health approach unravels worrying antimicrobial resistance patterns: A cross-sectional study in Kisii, Kenya.PloS one · 2025Article
- Evaluation of Fecal Inflammatory Biomarkers to Identify Bacterial Diarrhea Episodes: Systematic Review and Protocol for the Enterics for Global HealthOpen forum infectious diseases · 2024Article
- Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH)Open forum infectious diseases · 2024Article
- Exploring Natural Immune Responses toOpen forum infectious diseases · 2024Article
- Diarrhea Case Surveillance in the Enterics for Global HealthOpen forum infectious diseases · 2024Article
- Article
- Quantifying the Cost ofOpen forum infectious diseases · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
49 authors at 12 institutions in 9 countries.
Bri'Anna HorneCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Henry BadjiMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Md Taufiqur Rahman BhuiyanInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Lucero Romaina CachiqueAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Jennifer CornickInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Aneeta HotwaniDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Jane JumaCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
John Benjamin OchiengCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Mahamadou AbdouCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Evans ApondiCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Hannah E AtlasDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Alex O AwuorCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Kate S BakerInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Bubacarr E CeesayMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Mary CharlesMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Nigel A CunliffeInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Erika FeutzDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Sean R GalaganDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Ibrehima GuindoCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
M Jahangir HossainMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Junaid IqbalDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Fatima JallowMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Noumou Yakhouba KeitaCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Farhana KhanamInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Victor MaidenMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Katia Manzanares VillanuevaAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Oscar MitoCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Md Parvej MosharrafInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Joseph NkezeCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Usman N IkumapayiMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Maribel Paredes OlorteguiAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Patricia B PavlinacDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Tackeshy Pinedo VasquezAsociación Benéfica PRISMA, Iquitos, Loreto, Peru.
Firdausi QadriInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Farah Naz QamarDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Sonia QureshiDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Nazia RahmanInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Aminata SangareCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Sunil SenCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Pablo Peñataro YoriDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Mohammad Tahir YousafzaiDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Dilruba AhmedInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Khuzwayo C JereInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Margaret N KosekDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Richard OmoreCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Jasnehta Permala-BoothCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ousman SeckaMedical Research Council Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Sharon M TennantCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
MRC Unit the Gambia · GMInternational Centre for Diarrhoeal Disease Research · BDAga Khan University · PKCentre Pour le Développement des Vaccins-Mali · MLKenya Medical Research Institute · KEPrisma · PEUniversity of Washington · USUniversity of Liverpool · GBUniversity of Maryland, Baltimore · USMalawi-Liverpool-Wellcome Trust Clinical Research Programme · MWUniversity of Virginia · USUniversity of Cambridge · GB
Funding
Enabling Infectious Disease Research Capacity in the Peruvian AmazonD43TW010913 · FIC · UNIVERSITY OF VIRGINIA · PI Margaret N Kosek, MARIBEL PAREDES OLORTEGUI · 2018 to 2026
$2.8MFIC NIH HHS D43 TW010913Gates Foundation INV-028721Gates Foundation INV-031791Gates Foundation INV-036891
Abstract
Background: Methods: The Enterics for Global Health (EFGH) Conclusions: Data generated from EFGH using culture methods described herein can potentially be used for microbiological endpoints in future phase 3 clinical trials to evaluate vaccines against shigellosis and for other clinical and public health studies focused on these organisms.
Indexed as
childrendiarrheadysenterymicrobiologyShigella
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.